Cheapest Wegovy Semaglutide - UK Price From £69.00

Our Pricing

Wegovy Semaglutide UK Online Pharmacy

Published on: June 03, 2026

Searching for a wegovy semaglutide uk online pharmacy with all doses currently available? Cured Pharmacy stocks the complete range of Wegovy pens at £79.00, with transparent upfront pricing and free clinical consultations completed in under 3 minutes by our UK-registered prescribers.

How Wegovy Semaglutide Works for Weight Loss

Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA for chronic weight management in adults with obesity or overweight with weight-related comorbidities [1]. Semaglutide mimics a natural gut hormone that regulates appetite, slowing gastric emptying and increasing feelings of fullness after meals.

In the landmark STEP 1 trial involving 1,961 adults, participants using semaglutide 2.4mg weekly achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [1]. This represents one of the most significant weight loss outcomes seen in pharmaceutical trials to date, establishing semaglutide as a leading treatment option for eligible patients.

The medication works by binding to GLP-1 receptors in the brain's appetite regulation centres, reducing hunger signals and helping patients adhere to reduced-calorie diets more comfortably [2]. Clinical data shows that approximately 86% of trial participants achieved at least 5% body weight reduction, whilst 69% achieved 10% or greater reduction [1].

Wegovy Dosing Schedule and What to Expect

Wegovy follows a carefully designed dose escalation schedule to minimise gastrointestinal side effects whilst optimising weight loss outcomes. Your UK prescriber will typically start you on 0.25mg weekly for the first month, gradually increasing every four weeks through 0.5mg, 1mg, and 1.7mg before reaching the maintenance dose of 2.4mg [3].

This gradual titration approach, validated through clinical trials, allows your body to adapt to the medication's effects on gastric emptying and appetite regulation. Most patients report the greatest reduction in appetite once they reach the 1.7mg or 2.4mg maintenance doses, typically after 16-20 weeks of treatment [3].

At Cured Pharmacy, we stock all five Wegovy dose strengths, ensuring continuity of your treatment without interruption. Each pen delivers four weekly injections, and our clinical team provides comprehensive injection technique guidance as part of your consultation.

Managing Common Side Effects

The most frequently reported side effects are gastrointestinal: nausea, diarrhoea, vomiting, and constipation, particularly during dose escalation phases [2]. These effects are generally mild to moderate and diminish as treatment continues. Our superintendent pharmacist Tarun Kumar recommends eating smaller, more frequent meals and avoiding high-fat foods during the initial weeks to minimise discomfort.

Who Can Use Wegovy Semaglutide in the UK

Wegovy is licensed in the UK for adults with a body mass index (BMI) of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or obstructive sleep apnoea [3]. NICE guidance supports its use as part of a comprehensive weight management programme including dietary modification and increased physical activity.

During your free online consultation at Cured Pharmacy, our UK prescribers will assess your medical history, current medications, and weight loss goals to determine suitability. Wegovy is contraindicated in patients with personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease [3].

Patients taking certain medications, including other GLP-1 agonists or insulin, require careful assessment before starting treatment. Our clinical team reviews all potential drug interactions and ensures Wegovy is the safest, most appropriate option for your individual circumstances.

Pregnancy and Breastfeeding Considerations

Wegovy is not recommended during pregnancy or breastfeeding due to limited safety data. Women of childbearing potential should use effective contraception during treatment and discontinue semaglutide at least two months before a planned pregnancy [3]. Our prescribers discuss these considerations thoroughly during your consultation.

Wegovy vs Other Weight Loss Treatments Available in the UK

The UK market now offers several prescription weight loss treatments, each with distinct mechanisms of action and clinical profiles. Wegovy's semaglutide formulation acts solely on GLP-1 receptors, whilst newer dual-agonist treatments target additional pathways for potentially greater weight reduction in some patients.

Saxenda, another GLP-1 agonist containing liraglutide, requires daily injections rather than weekly administration. Clinical trials show semaglutide produces greater average weight loss than liraglutide, with the convenience advantage of once-weekly dosing improving treatment adherence [4].

Oral medications like Orlistat work through a completely different mechanism, blocking fat absorption in the digestive system rather than affecting appetite hormones. Orlistat typically produces more modest weight loss compared to injectable GLP-1 treatments, averaging 3-5% body weight reduction in clinical studies [5]. Your prescriber will discuss which treatment aligns best with your medical profile, lifestyle preferences, and weight loss objectives.

Why Stock Availability Matters for Wegovy Treatment

Consistent access to your prescribed Wegovy dose is essential for maintaining treatment efficacy and achieving optimal weight loss outcomes. Interruptions in therapy can lead to return of appetite, potential weight regain, and the need to restart dose escalation from lower strengths [2].

The UK has experienced periodic supply constraints for GLP-1 weight loss medications due to unprecedented demand. At Cured Pharmacy, we maintain robust stock levels across all five Wegovy doses, working directly with licensed UK wholesalers to ensure our patients can continue their treatment without disruption.

Our transparent stock status and upfront pricing mean you know exactly what's available before completing your consultation. We never accept payment for out-of-stock medications, and our clinical team proactively communicates with patients about their ongoing prescription needs.

Ordering Your Next Wegovy Prescription

Once you've completed your initial assessment and started treatment, reordering is straightforward. Our system tracks your prescription schedule, and you can request your next supply through your patient account. Our prescribers review each request to ensure continued appropriateness and monitor your progress towards your weight loss goals.

Getting Started with Wegovy at Cured Pharmacy

Beginning your Wegovy treatment journey starts with a free online consultation that takes under 3 minutes to complete. You'll answer questions about your medical history, current medications, weight loss goals, and any previous weight management attempts. Our UK-registered prescribers, overseen by superintendent pharmacist Tarun Kumar (GPhC 2233073), review every consultation individually.

If Wegovy is deemed clinically appropriate for you, we'll dispense your prescribed dose from our GPhC-registered pharmacy (9012511) and arrange discreet delivery to your preferred UK address. Your medication arrives in plain, unmarked packaging with comprehensive patient information leaflets and injection guidance.

We provide ongoing clinical support throughout your treatment. Our pharmacy team is available on (+44) 116 4646009 to answer questions about injection technique, side effect management, or dose progression. This continuity of care helps ensure you achieve the best possible outcomes from your Wegovy treatment whilst maintaining safety as our highest priority.

Scientific References

1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Rubino, D., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
3. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
4. O'Neil, P. M., et al. (2018). Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial. The Lancet, 392(10148), 637–649. https://doi.org/10.1016/S0140-6736(18)31773-2 [accessed 13 August 2026]
5. Yanovski, S. Z., & Yanovski, J. A. (2014). Long-term Drug Treatment for Obesity: A Systematic and Clinical Review. JAMA, 311(1), 74–86. https://doi.org/10.1001/jama.2013.281361 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on adherence to a reduced-calorie diet and increased physical activity alongside medication use.